Process View
Any process that modulates the occurrence or rate of lymphocyte death by apoptotic process.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of lymphocyte apoptotic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.981 | Mouse | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.933 | Human | |
| BIRC2 | baculoviral IAP repeat containing 2 | 0.875 | Human | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.736 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.734 | ||
| BID | BH3 interacting domain death agonist | 0.643 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.489 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.475 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.434 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.429 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.388 | Human | |
| TRAF1 | TNF receptor-associated factor 1 | 0.351 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.341 | ||
| INSR | insulin receptor | 0.283 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.244 | ||
| CD247 | CD247 molecule | 0.235 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.234 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.218 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.207 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.179 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.168 | ||
| CD2 | CD2 molecule | 0.161 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.149 | ||
| IL22RA2 | interleukin 22 receptor, alpha 2 | 0.146 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.145 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.136 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.130 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.126 | Mouse | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.123 | ||
| MSN | moesin | 0.120 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.117 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.115 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.114 | Human | |
| BCL2L1 | BCL2-like 1 | 0.112 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.109 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.098 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.093 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.089 | Mouse | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.088 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.083 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.083 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.081 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.080 | ||
| IDE | insulin-degrading enzyme | 0.074 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.065 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.061 | Human | |
| C9orf89 | chromosome 9 open reading frame 89 | 0.060 | ||
| PRKCZ | protein kinase C, zeta | 0.056 | Human | |
| BAK1 | BCL2-antagonist/killer 1 | 0.055 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.050 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.047 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.042 | ||
| UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.041 | ||
| CD6 | CD6 molecule | 0.041 | ||
| CTSW | cathepsin W | 0.041 | ||
| CD5 | CD5 molecule | 0.039 | ||
| KPNA1 | karyopherin alpha 1 (importin alpha 5) | 0.039 | ||
| CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.039 | ||
| TNF | tumor necrosis factor | 0.038 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.038 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.037 | ||
| SQSTM1 | sequestosome 1 | 0.036 | ||
| CD8A | CD8a molecule | 0.035 | ||
| RNR2 | l-rRNA | 0.034 | ||
| BIRC5 | baculoviral IAP repeat containing 5 | 0.033 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.033 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.033 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.033 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.033 | Mouse | |
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.033 | ||
| FSTL1 | follistatin-like 1 | 0.032 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.032 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.032 | ||
| CDCP1 | CUB domain containing protein 1 | 0.031 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.031 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.030 | ||
| BRCA1 | breast cancer 1, early onset | 0.030 | ||
| IL10 | interleukin 10 | 0.029 | ||
| IL32 | interleukin 32 | 0.029 | ||
| CA12 | carbonic anhydrase XII | 0.028 | ||
| MICA | MHC class I polypeptide-related sequence A | 0.027 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.026 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.026 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.025 | ||
| ANXA2 | annexin A2 | 0.025 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.024 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.024 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.024 | Human | |
| HPCAL4 | hippocalcin like 4 | 0.024 | ||
| S100A10 | S100 calcium binding protein A10 | 0.024 | ||
| ZHX1 | zinc fingers and homeoboxes 1 | 0.024 | ||
| EZR | ezrin | 0.023 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.023 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.022 | ||
| ARRB1 | arrestin, beta 1 | 0.022 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.022 | ||
| ANXA5 | annexin A5 | 0.021 | ||
| ATM | ataxia telangiectasia mutated | 0.021 | ||
| RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.020 | Mouse | |
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.020 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.019 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.019 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.019 | ||
| TMSB10 | thymosin beta 10 | 0.018 | ||
| RNF144B | ring finger protein 144B | 0.018 | ||
| CREBBP | CREB binding protein | 0.018 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.018 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.018 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.017 | ||
| IRS1 | insulin receptor substrate 1 | 0.017 | ||
| WRN | Werner syndrome, RecQ helicase-like | 0.017 | ||
| IL8 | interleukin 8 | 0.017 | ||
| PML | promyelocytic leukemia | 0.017 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.017 | ||
| BAD | BCL2-associated agonist of cell death | 0.017 | ||
| GLRX3 | glutaredoxin 3 | 0.017 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.017 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.016 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.016 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.016 | Human | |
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.015 | ||
| CRLF3 | cytokine receptor-like factor 3 | 0.015 | ||
| TCEB2 | transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) | 0.015 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.015 | ||
| WIPI1 | WD repeat domain, phosphoinositide interacting 1 | 0.015 | ||
| SYK | spleen tyrosine kinase | 0.014 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.014 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.014 | Human | |
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.014 | ||
| INCENP | inner centromere protein antigens 135/155kDa | 0.014 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.014 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.014 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.013 | ||
| RIPK4 | receptor-interacting serine-threonine kinase 4 | 0.013 | ||
| IFNG | interferon, gamma | 0.013 | ||
| CD83 | CD83 molecule | 0.013 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.013 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.013 | ||
| CDCA8 | cell division cycle associated 8 | 0.013 | ||
| RB1 | retinoblastoma 1 | 0.013 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.013 | ||
| CUL2 | cullin 2 | 0.012 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.012 | Human | |
| C1QB | complement component 1, q subcomponent, B chain | 0.012 | ||
| ANXA1 | annexin A1 | 0.012 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.012 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.012 | ||
| CD28 | CD28 molecule | 0.012 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.012 | ||
| UBD | ubiquitin D | 0.011 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.011 | ||
| SGOL1 | shugoshin-like 1 (S. pombe) | 0.011 | ||
| GSTO1 | glutathione S-transferase omega 1 | 0.011 | ||
| IL2RB | interleukin 2 receptor, beta | 0.011 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.011 | ||
| GNLY | granulysin | 0.011 | ||
| CD40LG | CD40 ligand | 0.011 | ||
| BAX | BCL2-associated X protein | 0.011 | Mouse | |
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.011 | ||
| EMP3 | epithelial membrane protein 3 | 0.011 | ||
| CD52 | CD52 molecule | 0.011 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.011 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.011 | ||
| IL7R | interleukin 7 receptor | 0.011 | ||
| ZBP1 | Z-DNA binding protein 1 | 0.011 | ||
| FPR3 | formyl peptide receptor 3 | 0.010 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.010 |